The global healthcare industry continues to prioritize the development of effective infectious disease treatments, especially for life-threatening viral infections such as Ebola. The Ebola treatment market has gained considerable attention due to increasing global preparedness initiatives, rising investments in infectious disease research, and the growing need for advanced antiviral therapies....
SPARK Website
عربي